PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule ▲ | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
F1C
|
isoGb4 (Isoglobotetraosylceramide; iGb4)
|
Oligoglycosylceramides
|
Rat intestine
|
GalNAc(b1-3)Gal(a1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
F1C
|
H5 type 1 pentaglycosylceramide (lacto-series)
|
Oligoglycosylceramides
|
Human small intestine
|
Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
F1C
|
Alpha-Galactosyl paragloboside
|
Oligoglycosylceramides
|
Rabbit erythrocytes
|
Gal(a1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
F1C
|
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH) (t18:0-h20:0-h24:0)
|
Oligoglycosylceramides
|
Human kidney tissues
|
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
F1C
|
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH) (d18:1-16:0/24:0)
|
Oligoglycosylceramides
|
Human erythrocytes
|
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
F1C
|
Lc4Cer (Lactotetraosylceramide)
|
Oligoglycosylceramides
|
Human meconium
|
Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
F1C
|
GD3(NeuAc)
|
Disialoglycosphingolipids
|
NeuAc(a2-8)NeuAc(a2-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
F1C
|
GD2
|
Disialoglycosphingolipids
|
GalNAc(b1-4)[NeuAc(a2-8)NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
F1C
|
GM3(NeuAc)
|
Monosialoglycosphingolipids
|
NeuAc(a2-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
F1C
|
GM1
|
Monosialoglycosphingolipids
|
Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01